This website is for UK healthcare professionals only and contains promotional content.

Report an adverse event here

NOTICE: Kyowa Kirin International has agreed a joint venture with Grünenthal GmbH for the Established Medicines portfolio. The new company, KKI NewCo (known as Grünenthal Meds), is responsible for the content on this page. For more information please click here.

Chronic Anal Fissure

Find out about RECTOGESIC® (glyceryl trinitrate 4 mg/g Rectal Ointment), the only topical treatment for adults specifically indicated for relief of pain associated with chronic anal fissure.1,2

Adverse Events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk/. Adverse Events should also be reported to Kyowa Kirin International UK NewCo Ltd, known as Grünenthal Meds on +44 (0)1896 664000, email PVUK@grunenthalmeds.com

CHRONIC ANAL FISSURE

Provided by
KKI NewCo (known as Grünenthal Meds)

RECTOGESIC® 4 mg/g Rectal Ointment is indicated in adults for relief of pain associated with chronic anal fissure.2

Click here for prescribing and adverse event reporting information.

LEARN MORE

Average:

  • References

    1. British National Formulary Online. Available at: https://bnf.nice.org.uk/treatment-summaries/anal-fissure/ Last accessed: July 2025.

    2. RECTOGESIC® (glyceryl trinitrate) Summary of Product Characteristics.

    M-RCG-UK-11-23-0004 July 2025

This website is for healthcare professionals only.

If you are a registered healthcare professional outside the UK please visit the Grünenthal Meds Website

M-GRM-HQ-11-24-0006 May 2025